- Report
- October 2026
- 387 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 494 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 350 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 256 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 378 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 309 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 397 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 192 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 186 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 183 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 283 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 349 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 149 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 174 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 180 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 174 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 280 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 186 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more